• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞颗粒蛋白抑制P物质诱导的人皮肤肥大细胞组胺释放。

Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells.

作者信息

Okayama Y, el-Lati S G, Leiferman K M, Church M K

机构信息

Immunopharmacology Group, Southampton General Hospital, England.

出版信息

J Allergy Clin Immunol. 1994 May;93(5):900-9. doi: 10.1016/0091-6749(94)90384-0.

DOI:10.1016/0091-6749(94)90384-0
PMID:7514197
Abstract

We have investigated the activity of the four principal cationic proteins of the eosinophil granules, major basic protein (MBP), eosinophil peroxidase (EPO), eosinophil-derived neurotoxin, and eosinophil cationic protein on histamine release from human skin mast cells. These four cationic proteins, over the concentration range of 10 to 200 micrograms/ml, did not induce significant histamine release, nor did they prime anti-IgE-induced histamine release from human skin mast cells significantly. However, a brief incubation (15 minutes) of two of the four principal eosinophil granule proteins, MBP and EPO, at concentrations of 50 to 200 micrograms/ml, caused a significant concentration-related inhibition of histamine release induced by 30 mumol/L substance P. The concentrations producing 50% inhibition for MBP and EPO on substance P-induced histamine release were 30 micrograms/ml and 100 micrograms/ml, respectively. This inhibitory effect appears to be a direct effect of these proteins on skin mast cells because purified (78% to 85%) skin mast cells displayed a similar response to MBP and EPO (n = 4). Also, when skin mast cells were incubated with 100 micrograms/ml MBP and EPO for 15 minutes and washed twice before activation by substance P, the inhibitory effect was not altered. These two proteins also inhibited histamine release induced by 10 micrograms/ml compound 48/80. These results suggest that MBP and EPO affect the same binding site(s) on skin mast cells as those of substance.

摘要

我们研究了嗜酸性粒细胞颗粒的四种主要阳离子蛋白,即主要碱性蛋白(MBP)、嗜酸性粒细胞过氧化物酶(EPO)、嗜酸性粒细胞衍生神经毒素和嗜酸性粒细胞阳离子蛋白对人皮肤肥大细胞组胺释放的作用。在10至200微克/毫升的浓度范围内,这四种阳离子蛋白均未诱导显著的组胺释放,也未显著增强抗IgE诱导的人皮肤肥大细胞组胺释放。然而,四种主要嗜酸性粒细胞颗粒蛋白中的两种,即MBP和EPO,在浓度为50至200微克/毫升时短暂孵育(15分钟),会对30微摩尔/升P物质诱导的组胺释放产生显著的浓度依赖性抑制。MBP和EPO对P物质诱导的组胺释放产生50%抑制的浓度分别为30微克/毫升和100微克/毫升。这种抑制作用似乎是这些蛋白对皮肤肥大细胞的直接作用,因为纯化的(78%至85%)皮肤肥大细胞对MBP和EPO表现出类似的反应(n = 4)。此外,当皮肤肥大细胞与100微克/毫升的MBP和EPO孵育15分钟并在被P物质激活前洗涤两次时,抑制作用未改变。这两种蛋白还抑制了10微克/毫升化合物48/80诱导的组胺释放。这些结果表明,MBP和EPO影响皮肤肥大细胞上与P物质相同的结合位点。

相似文献

1
Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells.嗜酸性粒细胞颗粒蛋白抑制P物质诱导的人皮肤肥大细胞组胺释放。
J Allergy Clin Immunol. 1994 May;93(5):900-9. doi: 10.1016/0091-6749(94)90384-0.
2
Eosinophil granule proteins are selective activators of human heart mast cells.嗜酸性粒细胞颗粒蛋白是人类心脏肥大细胞的选择性激活剂。
Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):200-2. doi: 10.1159/000237546.
3
[Effect of eosinophil major basic protein on histamine release from nasal epithelial mast cells].
Zhonghua Er Bi Yan Hou Ke Za Zhi. 1997 Aug;32(4):201-4.
4
Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins.嗜酸性粒细胞颗粒衍生的阳离子蛋白对嗜碱性粒细胞和大鼠肥大细胞组胺释放的刺激作用。
J Immunol. 1984 Oct;133(4):2180-5.
5
Eosinophil granule proteins activate human heart mast cells.嗜酸性粒细胞颗粒蛋白激活人心脏肥大细胞。
J Immunol. 1996 Aug 1;157(3):1219-25.
6
Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions.人嗜酸性粒细胞可诱导抗原激活的大鼠腹腔肥大细胞释放组胺:肥大细胞在迟发性过敏反应中的可能作用。
J Allergy Clin Immunol. 2001 Jun;107(6):993-1000. doi: 10.1067/mai.2001.114656.
7
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein.嗜酸性粒细胞颗粒主要碱性蛋白激活嗜碱性粒细胞和肥大细胞组胺释放。
J Exp Med. 1983 Jun 1;157(6):1981-91. doi: 10.1084/jem.157.6.1981.
8
Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor.嗜酸性粒细胞主要碱性蛋白可诱导人肺和脐血来源的肥大细胞发生非IgE依赖性激活,并受干细胞因子膜形式的调节。
Blood. 2003 Mar 1;101(5):1898-904. doi: 10.1182/blood-2002-05-1488. Epub 2002 Oct 10.
9
Stem cell factor influences mast cell mediator release in response to eosinophil-derived granule major basic protein.
Blood. 1998 Aug 1;92(3):1055-61.
10
Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization.嗜酸性粒细胞颗粒蛋白与皮肤的相互作用:检测限度、持久性和血管通透性
J Allergy Clin Immunol. 2003 Nov;112(5):988-94. doi: 10.1016/j.jaci.2003.08.028.

引用本文的文献

1
The Neuropeptide Substance P is Elevated in Sickle Cell Disease and is a Marker of Severity of Vaso-occlusive Crisis.神经肽P物质在镰状细胞病中升高,是血管闭塞性危象严重程度的标志物。
Niger Med J. 2024 Sep 26;65(4):398-402. doi: 10.60787/nmj-v65i3-419. eCollection 2024 Jul-Aug.
2
Peptides of major basic protein and eosinophil cationic protein activate human mast cells.主要碱性蛋白和嗜酸性粒细胞阳离子蛋白的肽可激活人肥大细胞。
Biochem Biophys Rep. 2019 Dec 25;21:100719. doi: 10.1016/j.bbrep.2019.100719. eCollection 2020 Mar.
3
Tissue remodeling in eosinophilic esophagitis.
嗜酸性粒细胞性食管炎中的组织重构。
Am J Physiol Gastrointest Liver Physiol. 2012 Dec 1;303(11):G1175-87. doi: 10.1152/ajpgi.00313.2012. Epub 2012 Sep 27.
4
Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte.分析嗜酸性粒细胞阳离子蛋白——揭示嗜酸性粒细胞功能的线索。
Respir Res. 2011 Jan 14;12(1):10. doi: 10.1186/1465-9921-12-10.
5
Immunological modulation of human cardiac mast cells.人类心脏肥大细胞的免疫调节
Neurochem Res. 1999 Sep;24(9):1195-202. doi: 10.1023/a:1020776807187.
6
Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes.P物质增强细胞因子诱导的类风湿性成纤维样滑膜细胞上血管细胞黏附分子-1(VCAM-1)的表达。
Clin Exp Immunol. 1998 Aug;113(2):269-75. doi: 10.1046/j.1365-2249.1998.00621.x.